The trademark application BLUEROCK was filed by BlueRock Therapeutics LP, a U.S. corporation (the "Applicant"). The application was published for oppositions on February 13, 2023, and it was registered by office on May 23, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on September 11, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Cells for medical or clinical use
Genetic material for medical or clinical use
Pharmaceuticals, therapeutics, and pharmaceutical preparations for the treatment of Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases
Pharmaceutical and therapeutic products in the nature of cells for human use for treating diseases through cell therapy or gene therapy
Pharmaceutical preparations for gene therapy and cell therapy.
The mark was filed in class 42 with Medical and scientific research services in the fields of gene therapy and cell therapy and pharmaceutical research and development services..
The mark was filed in class 44 with following description of goods:
Medical treatment services
Collection and preservation of human biological tissue, blood and cells